Mesenchymal stromal cell–based therapies for obesity-associated metabolic complications: Mechanistic insights, translational evidence, and future perspectives

Biomedicine & Pharmacotherapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles